Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

Abstract— This review considers critically the evidence for the involvement of mediators of innate and acquired immunity in various stages of atherosclerosis. Rapidly mobilized arms of innate immunity, including phagocytic leukocytes, complement, and proinflammatory cytokines, contribute to atherogenesis. In addition, adaptive immunity, with its T cells, antibodies, and immunoregulatory cytokines, powerfully modulates disease activity and progression. Atherogenesis involves cross talk between and shared pathways involved in adaptive and innate immunity. Immune processes can influence the balance between cell proliferation and death, between synthetic and degradative processes, and between pro- and antithrombotic processes. Various established and emerging risk factors for atherosclerosis modulate aspects of immune responses, including lipoproteins and their modified products, vasoactive peptides, and infectious agents. As we fill in the molecular details, new potential targets for therapies will doubtless emerge.

[1]  J. Borén,et al.  Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.

[2]  C. Garlanda,et al.  Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Mantovani,et al.  Long Pentraxin PTX3 Upregulates Tissue Factor Expression in Human Endothelial Cells: A Novel Link Between Vascular Inflammation and Clotting Activation , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[4]  G. Hansson,et al.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. , 2002, The Journal of clinical investigation.

[5]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[6]  R. Hynes,et al.  CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism , 2002, Nature Medicine.

[7]  S. Gordon,et al.  Scavenger receptors in innate immunity. , 2002, Current opinion in immunology.

[8]  James L. Young,et al.  Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages , 2002, The Journal of experimental medicine.

[9]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[10]  M. Fishbein,et al.  Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL , 2001, Circulation.

[11]  P. Libby,et al.  CD40 Signaling and Plaque Instability , 2001, Circulation research.

[12]  Ruslan Medzhitov,et al.  Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.

[13]  Masashi Komeda,et al.  Expression of SR-PSOX, a Novel Cell-Surface Scavenger Receptor for Phosphatidylserine and Oxidized LDL in Human Atherosclerotic Lesions , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Tedgui,et al.  Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability , 2001, Circulation.

[15]  Y. Tintut,et al.  Recent advances in multifactorial regulation of vascular calcification , 2001, Current opinion in lipidology.

[16]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[17]  Y. Chao,et al.  ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5. , 2001, Biochemical and biophysical research communications.

[18]  T. Kita,et al.  Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis , 2001, Current opinion in lipidology.

[19]  M. Newell,et al.  T Helper—Cell Phenotype Regulates Atherosclerosis in Mice Under Conditions of Mild Hypercholesterolemia , 2001, Circulation.

[20]  M. Cybulsky,et al.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.

[21]  P. Libby,et al.  Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. , 2001, The American journal of pathology.

[22]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[23]  S. Normark,et al.  Activation of inducible nitric oxide synthase/nitric oxide by curli fibers leads to a fall in blood pressure during systemic Escherichia coli infection in mice. , 2001, The Journal of infectious diseases.

[24]  A. Medvedev,et al.  Bacterial Lipopolysaccharide and IFN-γ Induce Toll-Like Receptor 2 and Toll-Like Receptor 4 Expression in Human Endothelial Cells: Role of NF-κB Activation1 , 2001, The Journal of Immunology.

[25]  N. Mackman,et al.  LPS induction of gene expression in human monocytes. , 2001, Cellular signalling.

[26]  M. Cybulsky,et al.  NF-κB: pivotal mediator or innocent bystander in atherogenesis? , 2001 .

[27]  Anders Hamsten,et al.  LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[28]  P. Libby,et al.  The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review , 2001, Cellular and Molecular Life Sciences CMLS.

[29]  Xinghua Zhou,et al.  Transfer of CD4+ T Cells Aggravates Atherosclerosis in Immunodeficient Apolipoprotein E Knockout Mice , 2000, Circulation.

[30]  A. Daugherty,et al.  Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice , 2000 .

[31]  R M Zinkernagel,et al.  Natural antibodies and complement link innate and acquired immunity. , 2000, Immunology today.

[32]  C. Giachelli,et al.  Osteopontin: a versatile regulator of inflammation and biomineralization. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[33]  P. Godowski,et al.  Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor for Escherichia and Salmonella Lipopolysaccharides1 , 2000, The Journal of Immunology.

[34]  Richard T. Lee,et al.  Overexpression of Eotaxin and the CCR3 Receptor in Human Atherosclerosis: Using Genomic Technology to Identify a Potential Novel Pathway of Vascular Inflammation , 2000, Circulation.

[35]  Y. Shoenfeld,et al.  Adoptive Transfer of β2-Glycoprotein I–Reactive Lymphocytes Enhances Early Atherosclerosis in LDL Receptor–Deficient Mice , 2000 .

[36]  G Olivetti,et al.  PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. , 2000, Circulation.

[37]  M. Daemen,et al.  Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Libby,et al.  Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Silverman,et al.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.

[40]  Y. Chao,et al.  Infectious Agents Are Not Necessary for Murine Atherogenesis , 2000, The Journal of experimental medicine.

[41]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[42]  M. Arditi,et al.  Bacterial Lipopolysaccharide Activates NF-κB through Toll-like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial Cells , 2000, The Journal of Biological Chemistry.

[43]  G. Hansson,et al.  Molecular Medicine © 2000 The Picower Institute Press Induction of Neonatal Tolerance to Oxidized Lipoprotein Reduces Atherosclerosis In ApoE Knockout Mice , 2000 .

[44]  H. G. Boman.  Innate immunity and the normal microflora , 2000, Immunological reviews.

[45]  P. Libby,et al.  Cutting Edge: Heat Shock Protein (HSP) 60 Activates the Innate Immune Response: CD14 Is an Essential Receptor for HSP60 Activation of Mononuclear Cells1 , 2000, The Journal of Immunology.

[46]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[47]  L. Curtiss,et al.  Participation of innate and acquired immunity in atherosclerosis , 2000, Immunologic research.

[48]  G. Hansson,et al.  Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[49]  M. Territo,et al.  Interleukin-10 blocks atherosclerotic events in vitro and in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[50]  Cecilia Soderberg-Naucler,et al.  The Human Cytomegalovirus Chemokine Receptor US28 Mediates Vascular Smooth Muscle Cell Migration , 1999, Cell.

[51]  M. Daemen,et al.  Requirement for CD154 in the progression of atherosclerosis , 1999, Nature Medicine.

[52]  M. Bureau,et al.  Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.

[53]  P. Libby,et al.  Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. , 1999, The Journal of clinical investigation.

[54]  S. Bhakdi,et al.  Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[55]  H. Rus,et al.  Complement activation and atherosclerosis. , 1999, Molecular immunology.

[56]  G. Hansson,et al.  Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. , 1999, Atherosclerosis.

[57]  R. Roubey.  Immunology of the Antiphospholipid Syndrome: Antibodies, Antigens, and Autoimmune Response , 1999, Thrombosis and Haemostasis.

[58]  P. Godowski,et al.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.

[59]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[60]  U. Andersson,et al.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.

[61]  Hansson,et al.  Detection of B Cells and Proinflammatory Cytokines in Atherosclerotic Plaques of Hypercholesterolaemic Apolipoprotein E Knockout Mice , 1999, Scandinavian journal of immunology.

[62]  P. Libby,et al.  Angiotensin induces inflammatory activation of human vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[63]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[64]  J. Heinecke.  Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. , 1999, The Journal of laboratory and clinical medicine.

[65]  A. Schmidt,et al.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.

[66]  C. Cabañas,et al.  Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin. , 1999, The Journal of clinical investigation.

[67]  Y. Shoenfeld,et al.  Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[68]  P. Libby,et al.  Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. , 1999, The Journal of clinical investigation.

[69]  S. Wright.  Toll, A New Piece in the Puzzle of Innate Immunity , 1999, The Journal of experimental medicine.

[70]  T. Kodama,et al.  The macrophage scavenger receptor type A directs modified proteins to antigen presentation , 1999, European journal of immunology.

[71]  K. Garcia,et al.  Structural basis of T cell recognition. , 1999, Annual review of immunology.

[72]  I. Tabas,et al.  Nonoxidative modifications of lipoproteins in atherogenesis. , 1999, Annual review of nutrition.

[73]  S. L. Hazen,et al.  Modification of proteins and lipids by myeloperoxidase. , 1999, Methods in enzymology.

[74]  E. Miller,et al.  Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[75]  J L Witztum,et al.  Oxidized phospholipids and isoprostanes in atherosclerosis. , 1998, Current opinion in lipidology.

[76]  IrisGoldberg,et al.  Induction of Early Atherosclerosis in LDL-Receptor–Deficient Mice Immunized With β2-Glycoprotein I , 1998 .

[77]  Y. Shoenfeld,et al.  Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. , 1998, Circulation.

[78]  K. Koch,et al.  Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. , 1998, Journal of the American College of Cardiology.

[79]  S. Kaveri,et al.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. , 1998, The Journal of clinical investigation.

[80]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[81]  G. Bondjers,et al.  Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. , 1998, Atherosclerosis.

[82]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[83]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[84]  R. Hynes,et al.  The combined role of P- and E-selectins in atherosclerosis. , 1998, The Journal of clinical investigation.

[85]  P. Libby,et al.  Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. , 1998, The Journal of clinical investigation.

[86]  S. Saccani,et al.  The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6) , 1998, The Journal of experimental medicine.

[87]  G. Hansson,et al.  Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. , 1998, The Journal of clinical investigation.

[88]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[89]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[90]  P. Libby,et al.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. , 1997, Circulation.

[91]  L. Berglund,et al.  Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[92]  J. Oksenberg,et al.  Analysis of the T-cell receptor repertoire in human atherosclerosis. , 1997, Cardiovascular research.

[93]  H. Kruth.  The fate of lipoprotein cholesterol entering the arterial wall , 1997, Current opinion in lipidology.

[94]  M. Krieger,et al.  The other side of scavenger receptors: pattern recognition for host defense , 1997, Current opinion in lipidology.

[95]  A Daugherty,et al.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.

[96]  H. Vlassara.  Recent Progress in Advanced Glycation End Products and Diabetic Complications , 1997, Diabetes.

[97]  Daniel Steinberg,et al.  Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.

[98]  P. Libby,et al.  Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. , 1997, Circulation.

[99]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[100]  P. Libby,et al.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. , 1997, The American journal of pathology.

[101]  J. D. Smith,et al.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[102]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[103]  J. Egido,et al.  Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. , 1997, Circulation.

[104]  P. Libby,et al.  Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[105]  P. Kovanen,et al.  Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. , 1996, Circulation.

[106]  M J Davies,et al.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.

[107]  G. Wick,et al.  The role of heat shock proteins in protection and pathophysiology of the arterial wall. , 1996, Molecular medicine today.

[108]  P. Shah,et al.  Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[109]  G. Hansson,et al.  Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. , 1996, The American journal of pathology.

[110]  A. Lanzavecchia,et al.  Mechanisms of antigen uptake for presentation. , 1996, Current opinion in immunology.

[111]  Y. Yazaki,et al.  Restricted Usage of T-Cell Receptor Vα-Vβ Genes in Infiltrating Cells in Aortic Tissue of Patients With Takayasu’s Arteritis , 1996 .

[112]  L. Demer,et al.  Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. , 1996, The Journal of clinical investigation.

[113]  T. Blundell,et al.  Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. , 1996, Blood.

[114]  P. Libby,et al.  Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β , 1996 .

[115]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[116]  P. Constantinides.  Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. , 1995, Circulation.

[117]  Michael Ginsberg,et al.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[118]  P. Kovanen.  Role of mast cells in atherosclerosis. , 1995, Chemical immunology.

[119]  P. Libby,et al.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.

[120]  Y. Bobryshev,et al.  Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta. , 1995, Archives of histology and cytology.

[121]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[122]  T. Eberlein,et al.  T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[123]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[124]  Y. Bobryshev,et al.  S-100 positive cells in human arterial intima and in atherosclerotic lesions. , 1995, Cardiovascular research.

[125]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[126]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[127]  J. Pober,et al.  Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. , 1994, Journal of immunology.

[128]  P. Kovanen,et al.  Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. , 1994, Circulation.

[129]  P. Libby,et al.  Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[130]  V. Ord,et al.  ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[131]  G. Hansson,et al.  Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.

[132]  J. Halperin,et al.  Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells , 1994, The Journal of experimental medicine.

[133]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[134]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[135]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[136]  V. Fuster,et al.  Atherogenesis and inflammation. , 1993, European heart journal.

[137]  Qingbo Xu,et al.  Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. , 1993, The Journal of clinical investigation.

[138]  M. Krieger,et al.  Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. , 1993, The Journal of biological chemistry.

[139]  A. Gown,et al.  Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[140]  G. Hansson,et al.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[141]  G. Hansson,et al.  Polyclonal origin of T lymphocytes in human atherosclerotic plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[142]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[143]  L. Klareskog,et al.  Role of hsp60 during Autoimmune and Bacterial Inflammation , 1991, Immunological reviews.

[144]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[145]  S. Schwartz,et al.  Cell proliferation in human coronary arteries. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[146]  A. Lusis,et al.  Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins , 1990, Nature.

[147]  J. Goldstein,et al.  Scavenging for receptors , 1990, Nature.

[148]  M. Brown,et al.  Atherosclerosis. Scavenging for receptors. , 1990, Nature.

[149]  G. Gabbiani,et al.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells , 1989, The Journal of experimental medicine.

[150]  G. Hansson,et al.  Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[151]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[152]  P. Libby,et al.  Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[153]  M. Gimbrone,et al.  Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. , 1986, The Journal of clinical investigation.

[154]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[155]  H. Dvorak,et al.  Cellular and vascular manifestations of cell-mediated immunity. , 1986, Human pathology.

[156]  P. Libby,et al.  Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. , 1986, Transplantation.

[157]  R. Cotran,et al.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.